We've updated our privacy policy. Click here to review the details. Tap here to review the details.
Activate your 30 day free trial to unlock unlimited reading.
Activate your 30 day free trial to continue reading.
This Presentation will give you a brief outlook on Pharmacovigilance which will be very useful for every Healthcare professional besides Public awareness.
Pharmacovigilance is the pharmaceutical science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products.
The obtained information is entered in the drug safety database, analyzed, and assessed by the experts to identify new signals.
Signal: Reported information on a possible causal relationship between an adverse event and a drug, of which the relationship is unknown or incompletely documented
previously.
The information generated on the basis of these reports helps in continuous assessment of the benefit-risk ratio of the medicines.
***** Thalidomide was first marketed in 1957 in West Germany, where it was available over the counter.When first released, thalidomide was promoted for anxiety, trouble sleeping, "tension", and morning sickness.While it was initially thought to be safe in pregnancy, concerns regarding birth defects arose until the medication was removed from the market in Europe in 1961.The total number of infants affected by use during pregnancy is estimated at 10,000, of which about 40% died around the time of birth.Those who survived had limb, eye, urinary tract, and heart problems. ****
This Presentation will give you a brief outlook on Pharmacovigilance which will be very useful for every Healthcare professional besides Public awareness.
Pharmacovigilance is the pharmaceutical science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products.
The obtained information is entered in the drug safety database, analyzed, and assessed by the experts to identify new signals.
Signal: Reported information on a possible causal relationship between an adverse event and a drug, of which the relationship is unknown or incompletely documented
previously.
The information generated on the basis of these reports helps in continuous assessment of the benefit-risk ratio of the medicines.
***** Thalidomide was first marketed in 1957 in West Germany, where it was available over the counter.When first released, thalidomide was promoted for anxiety, trouble sleeping, "tension", and morning sickness.While it was initially thought to be safe in pregnancy, concerns regarding birth defects arose until the medication was removed from the market in Europe in 1961.The total number of infants affected by use during pregnancy is estimated at 10,000, of which about 40% died around the time of birth.Those who survived had limb, eye, urinary tract, and heart problems. ****
You just clipped your first slide!
Clipping is a handy way to collect important slides you want to go back to later. Now customize the name of a clipboard to store your clips.The SlideShare family just got bigger. Enjoy access to millions of ebooks, audiobooks, magazines, and more from Scribd.
Cancel anytime.Unlimited Reading
Learn faster and smarter from top experts
Unlimited Downloading
Download to take your learnings offline and on the go
You also get free access to Scribd!
Instant access to millions of ebooks, audiobooks, magazines, podcasts and more.
Read and listen offline with any device.
Free access to premium services like Tuneln, Mubi and more.
We’ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
Thank you!